Strain-dependent differences in bone development, myeloid hyperplasia, morbidity and mortality in Ptpn2-deficient mice

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Wiede, Florian ^a   Chew, Sock Hui ^a   van Vliet, Catherine ^a,c   Poulton, Ingrid J ^b   Kyparissoudis, Konstantinos ^c   Sasmono, Tedjo ^a,e   Loh, Kim ^a   Tremblay, Michel L ^d   Godfrey, Dale I ^c   Sims, Natalie A ^b   Tiganis, Tony ^a  

^a MONASH UNIVERSITY   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MCGILL UNIVERSITY   (Canada)

^e EIJKMAN INSTITUTE FOR MOLECULAR BIOLOGY   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; PTPN2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE DEVELOPMENT; BONE MARROW DISEASE; CELL MATURATION; CONTROLLED STUDY; DIARRHEA; ERYTHROPOIESIS; GENE; GENE DISRUPTION; GENETIC RECOMBINATION; GROWTH RETARDATION; HOMOLOGOUS RECOMBINATION; IMMOBILIZATION; MORBIDITY; MORPHOMETRICS; MORTALITY; MOUSE; MYELOID HYPERPLASIA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2 DEFICIENCY; NONHUMAN; PROTEIN DEFICIENCY; PTPN2 GENE; REFLEX; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; SURVIVAL TIME; THYMOCYTE; TISSUE DISTRIBUTION; ANIMAL; BAGG ALBINO MOUSE; BONE REMODELING; CROSS BREEDING; GENETICS; HYPERPLASIA; METABOLISM; MOUSE MUTANT; PATHOLOGY; SPECIES DIFFERENCE;

MUS;

ANIMALS; B-LYMPHOCYTES; BONE DEVELOPMENT; BONE REMODELING; CROSSES, GENETIC; ERYTHROPOIESIS; HYPERPLASIA; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; SPECIES SPECIFICITY;

EID: 84860676102     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036703     Document Type: Article

References (49)

1. Tiganis T, Bennett AM, (2007) Protein tyrosine phosphatase function: the substrate perspective. Biochem J 402: 1-15.
2. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, et al. (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39: 857-864.
3. Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, et al. (2008) Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 359: 2767-2777.
4. The Wellcome Trust Case Control Consortium, (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
5. Long SA, Cerosaletti K, Wan JY, Ho JC, Tatum M, et al. (2011) An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells. Genes Immun 12: 116-125.
6. van Vliet C, Bukczynska PE, Puryer MA, Sadek CM, Shields BJ, et al. (2005) Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. Nat Immunol 6: 253-260.
7. Kleppe M, Lahortiga I, El Chaar T, De Keersmaecker K, Mentens N, et al. (2010) Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia. Nat Genet 42: 530-535.
8. Shimizu T, Miyakawa Y, Iwata S, Kuribara A, Tiganis T, et al. (2004) A novel mechanism for imatinib mesylate (STI571) resistance in CML cell line KT-1: role of TC-PTP in modulating signals downstream from the BCR-ABL fusion protein. Exp Hematol 32: 1057-1063.
9. Lu X, Chen J, Sasmono RT, Hsi ED, Sarosiek KA, et al. (2007) T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6. Mol Cell Biol 27: 2166-2179.
10. Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G,et al. Meta-analysis of genome-wide association studies in > 80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 123: 731-738.
11. Lee CF, Ling ZQ, Zhao T, Fang SH, Chang WC, et al. (2009) Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma. World J Gastroenterol 15: 356-365.
12. Klingler-Hoffmann M, Fodero-Tavoletti MT, Mishima K, Narita Y, Cavenee WK, et al. (2001) The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptor. J Biol Chem 276: 46313-46318.
13. Tiganis T, Kemp BE, Tonks NK, (1999) The protein tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signalling. J Biol Chem 274: 27768-27775.
14. Tiganis T, Bennett AM, Ravichandran KS, Tonks NK, (1998) Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase. Mol Cell Biol 18: 1622-1634.
15. Galic S, Hauser C, Kahn BB, Haj FG, Neel BG, et al. (2005) Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Mol Cell Biol 25: 819-829.
16. Galic S, Klingler-Hoffmann M, Fodero-Tavoletti MT, Puryer MA, Meng TC, et al. (2003) Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP. Mol Cell Biol 23: 2096-2108.
17. Fukushima A, Loh K, Galic S, Fam B, Shields B, et al. (2010) T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis. Diabetes 59: 1906-1914.
18. Simoncic PD, Bourdeau A, Lee-Loy A, Rohrschneider LR, Tremblay ML, et al. (2006) T-cell protein tyrosine phosphatase (Tcptp) is a negative regulator of colony-stimulating factor 1 signaling and macrophage differentiation. Mol Cell Biol 26: 4149-4160.
19. Simoncic PD, Lee-Loy A, Barber DL, Tremblay ML, McGlade CJ, (2002) The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr Biol 12: 446-453.
20. Shields BJ, Hauser C, Bukczynska PE, Court NW, Tiganis T, (2008) DNA replication stalling attenuates tyrosine kinase signaling to suppress S phase progression. Cancer Cell 14: 166-179.
21. ten Hoeve J, Ibarra-Sanchez MJ, Fu Y, Zhu W, Tremblay M, et al. (2002) Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol 22: 5662-5668.
22. Yamamoto T, Sekine Y, Kashima K, Kubota A, Sato N, et al. (2002) The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. Biochem Biophys Res Commun 297: 811-817.
23. Aoki N, Matsuda T, (2002) A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol Endocrinol 16: 58-69.
24. Wiede F, Shields BJ, Chew SH, Kyparissoudis K, van Vliet C, et al. (2011) T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice. J Clin Invest 121: 4758-4774.
25. You-Ten KE, Muise ES, Itie A, Michaliszyn E, Wagner J, et al. (1997) Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J Exp Med 186: 683-693.
26. Heinonen KM, Nestel FP, Newell EW, Charette G, Seemayer TA, et al. (2004) T cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. Blood.
27. Hassan SW, Doody KM, Hardy S, Uetani N, Cournoyer D, et al. (2010) Increased susceptibility to dextran sulfate sodium induced colitis in the T cell protein tyrosine phosphatase heterozygous mouse. PLoS ONE 5: e8868.
28. Bourdeau A, Dube N, Heinonen KM, Theberge JF, Doody KM, et al. (2007) TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-γ. Blood 109: 4220-4228.
29. Kaul A, Koster M, Neuhaus H, Braun T, (2000) Myf-5 revisited: loss of early myotome formation does not lead to a rib phenotype in homozygous Myf-5 mutant mice. Cell 102: 17-19.
30. Scacheri PC, Crabtree JS, Novotny EA, Garrett-Beal L, Chen A, et al. (2001) Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis 30: 259-263.
31. Zee T, Settembre C, Levine RL, Karsenty G, (2012) T-cell protein tyrosine phosphatase regulates bone resorption and whole-body insulin sensitivity through its expression in osteoblasts. Mol Cell Biol 32: 1080-1088.
32. Sims NA, Brennan K, Spaliviero J, Handelsman DJ, Seibel MJ, (2006) Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling. Am J Physiol Endocrinol Metab 290: E456-462.
33. Hogquist KA, Baldwin TA, Jameson SC, (2005) Central tolerance: learning self-control in the thymus. Nat Rev Immunol 5: 772-782.
34. Aliahmad P, Kaye J, (2008) Development of all CD4 T lineages requires nuclear factor TOX. J Exp Med 205: 245-256.
35. Samitas K, Lotvall J, Bossios A B cells: from early development to regulating allergic diseases. Arch Immunol Ther Exp (Warsz) 58: 209-225.
36. Tsiftsoglou AS, Vizirianakis IS, Strouboulis J, (2009) Erythropoiesis: model systems, molecular regulators, and developmental programs. IUBMB Life 61: 800-830.
37. Geissmann F, Jung S, Littman DR, (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
38. Fayad R, Sennello JA, Kim SH, Pini M, Dinarello CA, et al. (2005) Induction of thymocyte apoptosis by systemic administration of concanavalin A in mice: role of TNF-α, IFN-γ and glucocorticoids. Eur J Immunol 35: 2304-2312.
39. Loh K, Fukushima A, Zhang X, Galic S, Briggs D, et al. (2011) Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. Cell Metab 14: 684-699.
40. LeCouter JE, Kablar B, Hardy WR, Ying C, Megeney LA, et al. (1998) Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene. Mol Cell Biol 18: 7455-7465.
41. Rozmahel R, Wilschanski M, Matin A, Plyte S, Oliver M, et al. (1996) Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet 12: 280-287.
42. Bonyadi M, Rusholme SA, Cousins FM, Su HC, Biron CA, et al. (1997) Mapping of a major genetic modifier of embryonic lethality in TGFβ1 knockout mice. Nat Genet 15: 207-211.
43. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, et al. (1995) Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269: 230-234.
44. Sibilia M, Wagner EF, (1995) Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269: 234-238.
45. Walkley CR, Shea JM, Sims NA, Purton LE, Orkin SH, (2007) Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 129: 1081-1095.
46. Doody KM, Bussieres-Marmen S, Li A, Paquet M, Henderson JE, et al. (2011) T cell protein tyrosine phosphatase deficiency results in spontaneous synovitis and subchondral bone resorption in mice. Arthritis Rheum 64: 752-61.
47. Sims NA, Clement-Lacroix P, Da Ponte F, Bouali Y, Binart N, et al. (2000) Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest 106: 1095-1103.
48. Moore KA, Lemischka IR, (2006) Stem cells and their niches. Science 311: 1880-1885.
49. Adams GB, Scadden DT, (2006) The hematopoietic stem cell in its place. Nat Immunol 7: 333-337.